Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis

BACKGROUND: Rifapentine has potent activity against Mycobacterium tuberculosis but the optimal dose for tuberculosis treatment is unknown. OBJECTIVE: to determine antimicrobial activity, safety, and tolerability of rifapentine 450 mg or 600 mg administered daily during the first 8 weeks of pulmonary...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Int J Tuberc Lung Dis
Main Authors: Dawson, Rodney, Narunsky, Kim, Carman, David, Gupte, Nikhil, Whitelaw, Andrew, Efron, Anne, Barnes, Grace L., Hoffman, Jennifer, Chaisson, Richard E., McIlleron, Helen, Dorman, Susan E.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2015
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6783281/
https://ncbi.nlm.nih.gov/pubmed/26056101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.14.0868
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla